(CHRD) Chord Energy - Overview
Exchange: NASDAQ •
Country: United States •
Currency: USD •
Type: Common Stock •
ISIN: US6742152076
Stock: Oil, Gas, Liquids
Total Rating 45
Risk 61
Buy Signal -0.41
| Risk 5d forecast | |
|---|---|
| Volatility | 39.4% |
| Relative Tail Risk | 1.62% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | 0.64 |
| Alpha | 13.32 |
| Character TTM | |
|---|---|
| Beta | 0.708 |
| Beta Downside | 0.987 |
| Drawdowns 3y | |
|---|---|
| Max DD | 53.91% |
| CAGR/Max DD | 0.05 |
EPS (Earnings per Share)
Revenue
Description: CHRD Chord Energy March 05, 2026
Chord Energy Corporation (CHRD) is an independent exploration and production company. It focuses on acquiring, developing, and producing crude oil, natural gas, and natural gas liquids within the Williston Basin, a significant hydrocarbon-producing region in North America.
The company sells its extracted products to refiners, marketers, and other buyers with access to transportation infrastructure like pipelines and rail. The exploration and production sector is capital-intensive, requiring substantial investment in drilling and infrastructure. CHRD, founded in 2007 and headquartered in Houston, Texas, was formerly named Oasis Petroleum Inc. until July 2022.
Further research on ValueRay can provide more in-depth financial and operational data.
Piotroski VR‑10 (Strict, 0-10) 4.0
| Net Income: 44.5m TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.05 > 0.02 and ΔFCF/TA -1.72 > 1.0 |
| NWC/Revenue: 1.79% < 20% (prev -2.00%; Δ 3.79% < -1%) |
| CFO/TA 0.15 > 3% & CFO 2.06b > Net Income 44.5m |
| Net Debt (1.32b) to EBITDA (1.79b): 0.73 < 3 |
| Current Ratio: 1.06 > 1.5 & < 3 |
| Outstanding Shares: last quarter (56.8m) vs 12m ago -7.16% < -2% |
| Gross Margin: 17.65% > 18% (prev 0.25%; Δ 1740 % > 0.5%) |
| Asset Turnover: 36.92% > 50% (prev 40.29%; Δ -3.37% > 0%) |
| Interest Coverage Ratio: 4.04 > 6 (EBITDA TTM 1.79b / Interest Expense TTM 80.1m) |
Altman Z'' 1.11
| A: 0.01 (Total Current Assets 1.54b - Total Current Liabilities 1.45b) / Total Assets 13.39b |
| B: 0.15 (Retained Earnings 2.04b / Total Assets 13.39b) |
| C: 0.02 (EBIT TTM 323.6m / Avg Total Assets 13.21b) |
| D: 0.39 (Book Value of Equity 2.04b / Total Liabilities 5.31b) |
| Altman-Z'' Score: 1.11 = BB |
Beneish M -3.13
| DSRI: 0.93 (Receivables 1.12b/1.30b, Revenue 4.88b/5.25b) |
| GMI: 1.41 (GM 17.65% / 24.86%) |
| AQI: 0.66 (AQ_t 0.04 / AQ_t-1 0.06) |
| SGI: 0.93 (Revenue 4.88b / 5.25b) |
| TATA: -0.15 (NI 44.5m - CFO 2.06b) / TA 13.39b) |
| Beneish M-Score: -3.13 (Cap -4..+1) = AA |
What is the price of CHRD shares?
As of March 07, 2026, the stock is trading at USD 121.36 with a total of 1,936,708 shares traded.
Over the past week, the price has changed by +11.99%, over one month by +17.95%, over three months by +24.75% and over the past year by +24.95%.
Over the past week, the price has changed by +11.99%, over one month by +17.95%, over three months by +24.75% and over the past year by +24.95%.
Is CHRD a buy, sell or hold?
Chord Energy has received a consensus analysts rating of 4.40.
Therefore, it is recommended to buy CHRD.
- StrongBuy: 9
- Buy: 3
- Hold: 3
- Sell: 0
- StrongSell: 0
What are the forecasts/targets for the CHRD price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 125.6 | 3.5% |
| Analysts Target Price | 125.6 | 3.5% |
CHRD Fundamental Data Overview March 07, 2026
P/E Trailing = 40.3007
P/S = 1.4896
P/B = 0.8035
Revenue TTM = 4.88b USD
EBIT TTM = 323.6m USD
EBITDA TTM = 1.79b USD
Long Term Debt = 1.48b USD (from longTermDebt, two quarters ago)
Short Term Debt = 16.8m USD (from shortTermDebt, last quarter)
Debt = 1.50b USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 1.32b USD (from netDebt column, last quarter)
Enterprise Value = 8.15b USD (6.83b + Debt 1.50b - CCE 189.5m)
Interest Coverage Ratio = 4.04 (Ebit TTM 323.6m / Interest Expense TTM 80.1m)
EV/FCF = 11.42x (Enterprise Value 8.15b / FCF TTM 713.5m)
FCF Yield = 8.76% (FCF TTM 713.5m / Enterprise Value 8.15b)
FCF Margin = 14.63% (FCF TTM 713.5m / Revenue TTM 4.88b)
Net Margin = 0.91% (Net Income TTM 44.5m / Revenue TTM 4.88b)
Gross Margin = 17.65% ((Revenue TTM 4.88b - Cost of Revenue TTM 4.02b) / Revenue TTM)
Gross Margin QoQ = 10.37% (prev 14.87%)
Tobins Q-Ratio = 0.61 (Enterprise Value 8.15b / Total Assets 13.39b)
Interest Expense / Debt = 1.78% (Interest Expense 26.8m / Debt 1.50b)
Taxrate = 27.15% (31.5m / 115.9m)
NOPAT = 235.8m (EBIT 323.6m * (1 - 27.15%))
Current Ratio = 1.06 (Total Current Assets 1.54b / Total Current Liabilities 1.45b)
Debt / Equity = 0.19 (Debt 1.50b / totalStockholderEquity, last quarter 8.08b)
Debt / EBITDA = 0.73 (Net Debt 1.32b / EBITDA 1.79b)
Debt / FCF = 1.84 (Net Debt 1.32b / FCF TTM 713.5m)
Total Stockholder Equity = 8.22b (last 4 quarters mean from totalStockholderEquity)
RoA = 0.34% (Net Income 44.5m / Total Assets 13.39b)
RoE = 0.54% (Net Income TTM 44.5m / Total Stockholder Equity 8.22b)
RoCE = 3.34% (EBIT 323.6m / Capital Employed (Equity 8.22b + L.T.Debt 1.48b))
RoIC = 2.53% (NOPAT 235.8m / Invested Capital 9.33b)
WACC = 7.22% (E(6.83b)/V(8.34b) * Re(8.52%) + D(1.50b)/V(8.34b) * Rd(1.78%) * (1-Tc(0.27)))
Discount Rate = 8.52% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: 33.33 | Cagr: 14.87%
[DCF] Terminal Value 80.73% ; FCFF base≈795.4m ; Y1≈776.0m ; Y5≈782.1m
[DCF] Fair Price = 263.5 (EV 16.30b - Net Debt 1.32b = Equity 14.99b / Shares 56.9m; r=7.22% [WACC]; 5y FCF grow -3.47% → 2.90% )
EPS Correlation: -77.95 | EPS CAGR: -39.30% | SUE: -0.67 | # QB: 0
Revenue Correlation: 74.36 | Revenue CAGR: 16.81% | SUE: 1.16 | # QB: 3
EPS next Quarter (2026-06-30): EPS=1.10 | Chg7d=+0.011 | Chg30d=+0.151 | Revisions Net=+0 | Analysts=13
EPS current Year (2026-12-31): EPS=5.34 | Chg7d=+0.997 | Chg30d=+0.402 | Revisions Net=-1 | Growth EPS=-43.9% | Growth Revenue=-11.7%
EPS next Year (2027-12-31): EPS=9.02 | Chg7d=+0.369 | Chg30d=+0.200 | Revisions Net=-1 | Growth EPS=+68.7% | Growth Revenue=+10.7%
[Analyst] Revisions Ratio: +0.00 (1 Up / 1 Down within 30d for Next Quarter)
[Growth] Implied Growth Rate = 6.0% (Discount Rate 8.5% - Earnings Yield 2.5%)
[Growth] Growth Spread = -18.3% (Analyst -12.2% - Implied 6.0%)
P/S = 1.4896
P/B = 0.8035
Revenue TTM = 4.88b USD
EBIT TTM = 323.6m USD
EBITDA TTM = 1.79b USD
Long Term Debt = 1.48b USD (from longTermDebt, two quarters ago)
Short Term Debt = 16.8m USD (from shortTermDebt, last quarter)
Debt = 1.50b USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 1.32b USD (from netDebt column, last quarter)
Enterprise Value = 8.15b USD (6.83b + Debt 1.50b - CCE 189.5m)
Interest Coverage Ratio = 4.04 (Ebit TTM 323.6m / Interest Expense TTM 80.1m)
EV/FCF = 11.42x (Enterprise Value 8.15b / FCF TTM 713.5m)
FCF Yield = 8.76% (FCF TTM 713.5m / Enterprise Value 8.15b)
FCF Margin = 14.63% (FCF TTM 713.5m / Revenue TTM 4.88b)
Net Margin = 0.91% (Net Income TTM 44.5m / Revenue TTM 4.88b)
Gross Margin = 17.65% ((Revenue TTM 4.88b - Cost of Revenue TTM 4.02b) / Revenue TTM)
Gross Margin QoQ = 10.37% (prev 14.87%)
Tobins Q-Ratio = 0.61 (Enterprise Value 8.15b / Total Assets 13.39b)
Interest Expense / Debt = 1.78% (Interest Expense 26.8m / Debt 1.50b)
Taxrate = 27.15% (31.5m / 115.9m)
NOPAT = 235.8m (EBIT 323.6m * (1 - 27.15%))
Current Ratio = 1.06 (Total Current Assets 1.54b / Total Current Liabilities 1.45b)
Debt / Equity = 0.19 (Debt 1.50b / totalStockholderEquity, last quarter 8.08b)
Debt / EBITDA = 0.73 (Net Debt 1.32b / EBITDA 1.79b)
Debt / FCF = 1.84 (Net Debt 1.32b / FCF TTM 713.5m)
Total Stockholder Equity = 8.22b (last 4 quarters mean from totalStockholderEquity)
RoA = 0.34% (Net Income 44.5m / Total Assets 13.39b)
RoE = 0.54% (Net Income TTM 44.5m / Total Stockholder Equity 8.22b)
RoCE = 3.34% (EBIT 323.6m / Capital Employed (Equity 8.22b + L.T.Debt 1.48b))
RoIC = 2.53% (NOPAT 235.8m / Invested Capital 9.33b)
WACC = 7.22% (E(6.83b)/V(8.34b) * Re(8.52%) + D(1.50b)/V(8.34b) * Rd(1.78%) * (1-Tc(0.27)))
Discount Rate = 8.52% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: 33.33 | Cagr: 14.87%
[DCF] Terminal Value 80.73% ; FCFF base≈795.4m ; Y1≈776.0m ; Y5≈782.1m
[DCF] Fair Price = 263.5 (EV 16.30b - Net Debt 1.32b = Equity 14.99b / Shares 56.9m; r=7.22% [WACC]; 5y FCF grow -3.47% → 2.90% )
EPS Correlation: -77.95 | EPS CAGR: -39.30% | SUE: -0.67 | # QB: 0
Revenue Correlation: 74.36 | Revenue CAGR: 16.81% | SUE: 1.16 | # QB: 3
EPS next Quarter (2026-06-30): EPS=1.10 | Chg7d=+0.011 | Chg30d=+0.151 | Revisions Net=+0 | Analysts=13
EPS current Year (2026-12-31): EPS=5.34 | Chg7d=+0.997 | Chg30d=+0.402 | Revisions Net=-1 | Growth EPS=-43.9% | Growth Revenue=-11.7%
EPS next Year (2027-12-31): EPS=9.02 | Chg7d=+0.369 | Chg30d=+0.200 | Revisions Net=-1 | Growth EPS=+68.7% | Growth Revenue=+10.7%
[Analyst] Revisions Ratio: +0.00 (1 Up / 1 Down within 30d for Next Quarter)
[Growth] Implied Growth Rate = 6.0% (Discount Rate 8.5% - Earnings Yield 2.5%)
[Growth] Growth Spread = -18.3% (Analyst -12.2% - Implied 6.0%)